Application 078276
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 5MG | No | No |
| 002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 20MG | No | No |
| 003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078276-001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | ||
| A078276-002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | ||
| A078276-003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078276-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2016-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078276-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2016-10-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078276-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2016-10-26 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A078276-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A078276-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A078276-003 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078276-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078276-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078276-003 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A078276-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A078276-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A078276-003 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A078276-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A078276-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A078276-003 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A078276-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A078276-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A078276-003 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A078276-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A078276-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A078276-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A078276-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A078276-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A078276-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A078276-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A078276-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A078276-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | REMEDYREPACK INC. | 33429d86-878e-4e1e-a940-70a8a56a15ea | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | cae6cb47-0a2c-4c69-894b-89d389cab49f | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 04f0107b-4194-4412-9ebb-3219da5a9ac9 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Chartwell RX, LLC | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lifestar Pharma LLC | a337a621-bf57-4aa4-8224-4356fa2cdbc4 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Golden State Medical Supply, Inc. | 865c2765-5072-d029-e053-2a91aa0a098e | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 8466711a-3a02-4675-96db-c7cffdb89778 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Accord Healthcare Inc. | e5dbca00-4e1b-4479-b829-021b11bc021e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | eff499eb-a0e4-4240-870c-83bb53434cc2 | 2025-10-24 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 640936ee-55a6-47ae-a1ad-cffae316b925 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 3c001b8d-f6c1-4316-b8c0-590b2fa7f2e5 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 38f7f201-3a3a-4922-bde7-d34187b4c81d | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | e43e5643-b258-469d-812a-887f913cfe71 | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Benicar | OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | dc3f1fd4-5578-4c5d-be7b-12e3f8f3e7df | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Macleods Pharmaceuticals Limited | 24e308cc-7cec-4054-9627-66f743ed71b0 | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | Olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Ascend Laboratories, LLC | 142b735a-e1cd-46e1-a523-3ef061001bf9 | 2025-08-11 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 53b8d406-a4f3-46ee-9aec-d70f7d806876 | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 0a49d951-dd1b-413b-99e5-d3119267c46c | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Jubilant Cadista Pharmacuticals Inc. | d5658d8a-f8e9-454d-89a9-34884e753001 | 2025-03-23 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Modavar Pharmaceuticals LLC | 1f430fc9-bd4c-4328-a4a2-501ec991029b | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-7012 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7012 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7112 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7112 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7124 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7124 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 42292-036 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Institutional Inc. | ANDA | Current |
| 42292-037 | Olmesartan Medoxomil | olmesartan medoxomil | Mylan Institutional Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 45728 | ORIG | 2016-10-31 |